Cemtrex Inc. short interest in 2018
In 2018, Cemtrex Inc.'s disclosed short interest ran from 3.57% of shares outstanding on 12 Jan 2018 to 2.72% on 31 Dec 2018, a change of -0.85 percentage points. The year's high was 4.68% on 29 Mar 2018 and its low 2.36% on 30 Nov 2018, averaging 3.17% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 16.63 days on 30 Apr 2018. Full history: Cemtrex Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2018 in figures
- Start of year
- 3.57% (12 Jan 2018)
- End of year
- 2.72% (31 Dec 2018)
- Change
- -0.85 pp
- High
- 4.68% (29 Mar 2018)
- Low
- 2.36% (30 Nov 2018)
- Average
- 3.17%
- Highest days to cover
- 16.63 (30 Apr 2018)
- SEC filings marked
- 3
Every report in 2018
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Jan 2018 | 3.57% | 6.38 | |
| 31 Jan 2018 | 3.91% | 1.89 | |
| 15 Feb 2018 | 3.80% | 5.66 | 10-Q filed |
| 28 Feb 2018 | 4.10% | 8.50 | |
| 15 Mar 2018 | 3.96% | 6.36 | |
| 29 Mar 2018 | 4.68% | 3.36 | |
| 13 Apr 2018 | 3.95% | 13.22 | |
| 30 Apr 2018 | 3.99% | 16.63 | |
| 15 May 2018 | 3.38% | 14.97 | 10-Q filed |
| 31 May 2018 | 3.10% | 2.84 | |
| 15 Jun 2018 | 2.81% | 6.54 | |
| 29 Jun 2018 | 2.71% | 8.04 | |
| 13 Jul 2018 | 2.68% | 9.63 | |
| 31 Jul 2018 | 3.01% | 2.51 | |
| 15 Aug 2018 | 3.07% | 5.87 | 10-Q filed |
| 31 Aug 2018 | 2.43% | 3.61 | |
| 14 Sep 2018 | 2.65% | 4.28 | |
| 28 Sep 2018 | 2.41% | 6.69 | |
| 15 Oct 2018 | 2.83% | 5.02 | |
| 31 Oct 2018 | 2.93% | 6.70 | |
| 15 Nov 2018 | 2.38% | 6.05 | |
| 30 Nov 2018 | 2.36% | 6.23 | |
| 14 Dec 2018 | 2.69% | 5.37 | |
| 31 Dec 2018 | 2.72% | 3.91 |
See also: Cemtrex Inc.'s full history · most shorted US stocks of 2018 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.